These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21196410)

  • 1. RAGE and its ligands in bone metabolism.
    Zhou Z; Xiong WC
    Front Biosci (Schol Ed); 2011 Jan; 3(2):768-76. PubMed ID: 21196410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RAGE signaling in osteoporosis.
    Zhou J; Liu S; Bi S; Kong W; Qian R; Xie X; Zeng M; Jiang X; Liao Z; Shuai M; Liu W; Cheng L; Wu M
    Biomed Pharmacother; 2023 Sep; 165():115044. PubMed ID: 37354815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.
    Leung SS; Forbes JM; Borg DJ
    Curr Diab Rep; 2016 Oct; 16(10):100. PubMed ID: 27612847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Receptor for Advanced Glycation End-Products (RAGE) Signaling on Intestinal Ischemic Damage in Mice.
    Makino Y; Munakata S; Ueyama T; Honjo K; Kawano S; Takahashi M; Kojima Y; Tomiki Y; Sakamoto K
    Eur Surg Res; 2019; 60(5-6):239-247. PubMed ID: 31914449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of osteoclast function and bone mass by RAGE.
    Zhou Z; Immel D; Xi CX; Bierhaus A; Feng X; Mei L; Nawroth P; Stern DM; Xiong WC
    J Exp Med; 2006 Apr; 203(4):1067-80. PubMed ID: 16606672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting RAGE Signaling in Inflammatory Disease.
    Hudson BI; Lippman ME
    Annu Rev Med; 2018 Jan; 69():349-364. PubMed ID: 29106804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGB1 expression and release by bone cells.
    Charoonpatrapong K; Shah R; Robling AG; Alvarez M; Clapp DW; Chen S; Kopp RP; Pavalko FM; Yu J; Bidwell JP
    J Cell Physiol; 2006 May; 207(2):480-90. PubMed ID: 16419037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.
    Yan SF; Ramasamy R; Schmidt AM
    J Mol Med (Berl); 2009 Mar; 87(3):235-47. PubMed ID: 19189073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting receptors of advanced glycation end products (RAGE): Preventing diabetes induced cancer and diabetic complications.
    Chhipa AS; Borse SP; Baksi R; Lalotra S; Nivsarkar M
    Pathol Res Pract; 2019 Nov; 215(11):152643. PubMed ID: 31564569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Immune Tolerance Role of the HMGB1-RAGE Axis.
    Watanabe H; Son M
    Cells; 2021 Mar; 10(3):. PubMed ID: 33807604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: A Literature Review.
    De Martinis M; Ginaldi L; Sirufo MM; Pioggia G; Calapai G; Gangemi S; Mannucci C
    Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32204562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products inflammatory signaling pathways.
    Nakajima S; Ogawa N; Yokoue N; Tachibana H; Tamada K; Okazawa M; Sato A; Oyama T; Abe H; Kamiya T; Yoshimori A; Yoshizawa K; Inoue S; Yokomizo T; Uchiumi F; Abe T; Tanuma SI
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1155-1161. PubMed ID: 33041002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ousting RAGE in melanoma: A viable therapeutic target?
    Syed DN; Aljohani A; Waseem D; Mukhtar H
    Semin Cancer Biol; 2018 Apr; 49():20-28. PubMed ID: 29079306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of HMGB1 signaling pathways in Amyotrophic lateral sclerosis (ALS): From molecular mechanisms to pre-clinical results.
    Paudel YN; Angelopoulou E; Piperi C; Othman I; Shaikh MF
    Pharmacol Res; 2020 Jun; 156():104792. PubMed ID: 32278047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.
    Prasad K
    Mol Cell Biochem; 2019 Sep; 459(1-2):95-112. PubMed ID: 31079281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ligands of RAGE-Proteins: Role in Intercellular Communication and Pathogenesis of Inflammation].
    Uspenskaya YA; Komleva YK; Pozhilenkova EA; Salmin VV; Lopatina OL; Fursov AA; Lavrentiev PV; Belova OA; Salmina AB
    Vestn Ross Akad Med Nauk; 2015; (6):694-703. PubMed ID: 27093797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs.
    Behl T; Sharma E; Sehgal A; Kaur I; Kumar A; Arora R; Pal G; Kakkar M; Kumar R; Bungau S
    Mol Biol Rep; 2021 Feb; 48(2):1869-1881. PubMed ID: 33479829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
    Nguyen AH; Detty SQ; Agrawal DK
    Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is HMGB1 an osteocyte alarmin?
    Bidwell JP; Yang J; Robling AG
    J Cell Biochem; 2008 Apr; 103(6):1671-80. PubMed ID: 17948903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation.
    Sparvero LJ; Asafu-Adjei D; Kang R; Tang D; Amin N; Im J; Rutledge R; Lin B; Amoscato AA; Zeh HJ; Lotze MT
    J Transl Med; 2009 Mar; 7():17. PubMed ID: 19292913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.